SCHEMBL15463572

SCHEMBL15463572

O=C(Nc1ccccc1F)c1ccccc1F

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.70
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
TDP1 Q9NUW8 2/20 0.69
RAB9A P51151 5/20 0.64
NPC1 O15118 3/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
L3MBTL1 Q9Y468 3/20 0.64
LMNA P02545 1/20 0.62
USP2 O75604 1/20 0.60
ALDH1A1 P00352 1/20 0.60
GLA P06280 1/20 0.60
TSHR P16473 1/20 0.60
ATM Q13315 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
GAA P10253 1/20 0.60
KCNMA1 Q12791 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2701324 0.89 HTT (0.76) HTTMEN1KMT2ARAB9ANPC1
SCHEMBL31098214 0.87 HTT (0.73) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL15541786 0.87 HTT (0.64) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL2699444 0.87 HTT (0.69) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL14855912 0.85 L3MBTL1 (0.61) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL5224838 0.85 RAB9A (0.62) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL31424196 0.85 RAB9A (0.62) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL17772176 0.85 HTT (0.63) HTTMEN1KMT2ARAB9ANPC1
SCHEMBL2308520 0.85 HTT (0.62) HTTMEN1KMT2ATDP1RAB9A
SCHEMBL4716633 0.85 TDP1 (0.61) HTTMEN1KMT2ATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3481394-A1 THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER Janssen Pharmaceutica N.V. (BE) 2019-05-15 EP claimed
WO-2018009694-A1 THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2018-01-11 WO claimed
EP-3500259-A1 THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER Janssen Pharmaceutica NV (BE) 2019-06-26 EP disclosed
WO-2018037342-A1 THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2018-03-01 WO disclosed
US-9056284-B2 Chlorine resistant amides, polyamides, and membranes made from the same THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE INTERIOR (US) 2015-06-16 US disclosed
US-9056284-B2 Chlorine resistant amides, polyamides, and membranes made from the same THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE INTERIOR (US) 2015-06-16 US disclosed
US-20140042082-A1 CHLORINE RESISTANT AMIDES, POLYAMIDES, AND MEMBRANES MADE FROM THE SAME THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE INTERIOR 2014-02-13 US disclosed
US-20140042082-A1 CHLORINE RESISTANT AMIDES, POLYAMIDES, AND MEMBRANES MADE FROM THE SAME THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE INTERIOR 2014-02-13 US disclosed